A previously undescribed species of Alternaria was isolated from the leaves of Helianthus tuberosus bearing necrotic lesions. When this isolate was grown in liquid medium two phytotoxic metabolites were produced. These compounds were identified as pyrenocine A and pyrenocine B. The former metabolite was found to be lethal to both isolated protoplasts and whole leaf tissue of Helianthus.
Introduction
Two metabolites which have been assigned the trivial names pyrenocine A and pyrenocine B, were first described by Sato et al. as products of the onion pink root fungus Pyrenochaeta terrestris [1] . Subse quently these authors revised the structures of both compounds, following X-ray crystallographic studies, as shown below for pyrenocine A (I) and pyrenocine B (II) [2] . Pyrenocine A was thus shown to be identical to citreopyrone which was reported by Niwa et al. [3] as a metabolite of Penicillium citreoviride. Members of the fungal genus Alternaria are known to be versatile in their synthesis of phytotoxic secondary metabolites [4] [5] [6] . In this report we de scribe the isolation of a novel Alternaria species which produced two toxic compounds which were identified as I and II. The fungus was isolated from diseased leaves of the Jerusalem artichoke (Helian thus tuberosus L., Compositae), a plant commonly grown for its edible tubers and as a commercial source of inulin. 
Results and Discussion
The fungus used in this study was isolated from leaves of greenhouse-grown H. tuberosus bearing numerous necrotic lesions. This isolate was main tained in pure culture on V-8 juice agar. Following incubation on this medium, at 28 °C under continu ous illumination provided by cool white fluorescent lights, sporulation readily occurred. Microscopic ob servation of sporulating cultures revealed muriform conidial morphology typical of the genus Alternaria [7, 8] . However, this species is morphologically and physiologically distinct from the sunflower pathogen Alternaria helianthi (Hansf.) Tubaki and Nishihara [9] which is pathogenic to many members of the genus Helianthus including H. tuberosus [10] . The assignment of the novel isolate as a member of the genus Alternaria was subsequently confirmed inde pendently [11] . The organism was grown in liquid shake cultures on either modified Czapek Dox broth (medium CD) [12] or on medium derived from the aqueous extract of the fresh leaves of the sunflower plant (Helianthus annuus L.). This latter medium is referred to here as sunflower extract medium (SEM). Incubation of liquid cultures was performed at 28 °C on a gyratory shaker operating at 170 rpm. After growth for 3-4 weeks the culture filtrate was partitioned against diethyl ether. The organic phase was chromatographed on thin layer plates of silica gel using diethyl ether as developing solvent. Com pounds I and II were visualised on chromatograms under short wavelength UV light. Further purifica tion of the two metabolites, when necessary, was achieved by HPLC on a reverse phase Clg [iBondapak column. Under these conditions I and II eluted with retention times of 3.63 and 2.94 respec tively. Their identification was achieved by spectral comparison (UV, MS and 'H NMR) with authentic samples of pyrenocine A and B isolated from cul-tures of P. terrestris. Both compounds readily crystal lized as colourless needles from chloroform/ethanol. The phytotoxin related metabolite pyrenocine C [13] reported to co-occur with pyrenocines A and B in cultures of P. terrestris was not encountered in the present investigation.
In reports on the production of the pyrenocines by the onion pink root pathogen, P. terrestris, bioassays for phytotoxicity have examined their effect on the inhibition of seedling elongation in various species [1, 14] . In the present investigation, since the fungus was associated with the aerial parts of the plant, we examined the effect of pyrenocine A on leaves of the commonly cultivated oil seed crop plant, Helianthus annuus, as well as the response of H. tuberosus to this toxin. In phytotoxicity assays utilising whole leaf tissue of H. annuus, pyrenocine A applied as an aqueous solution in 2% dimethyl sulfoxide (DMSO) resulted in a necrotic lesion at concentrations of 12 ppm or lower, within 4 days of application (Ta ble I). Of the two plant species examined H. annuus was more sensitive to the toxin over the whole con centration range in each of two treatments, as com pared with H. tuberosus. Thus the former species exhibited symptoms more rapidly than the latter fol lowing similar application of the compound at the same concentration, and subsequent symptom ex pression was more severe in the case of H. annuus than for H. tuberosus. For example, 24 h following the application of 3.3 [xg pyrenocine A in a 10 |il droplet H. annuus showed a dark brown necrotic spot 2 mm in diameter. The corresponding lesion for H. tuberosus was a grey-brown necrotic fleck with a diameter of < 1 mm. The assay results indicating differential toxicity to the two Helianthus species are illustrated further in Table I which gives the size of the necrotic lesion 93 h post-application. The induc tion of a necrotic response following the application of pyrenocine A was manifest both in the presence and absence of a laceration of the leaf cuticle, dem onstrating the relatively rare ability of pyrenocine A among toxic fungal metabolites to readily penetrate intact leaf surfaces. However, predictably, symptoms appeared earlier and/or at lower concentrations in the presence (as opposed to the absence) of a needle puncture (Table I) . As well as necrosis, yellowing of leaf tissue surrounding areas of application of pyre nocine A was generally observed. Pyrenocine A was also toxic to leaf tissue of the noxious weed Abutilon theophrasti Medic., although levels of activity were less than those expressed in Helianthus (unpublished results).
Bioassays were also performed with isolated pro toplasts of H. annuus. In this case activity was moni tored by decrease in protoplast viability using the fluorescein diacetate staining technique [15] . After incubation in the presence of different levels of pyre nocine A for 4 days, values for the viability of iso lated protoplasts, expressed as a percentage of viabil ity of the control treatment, were recorded as zero and 73% for concentrations of 30 and 0.3 ppm re spectively. These concentrations represent the high est and lowest levels tested (Fig.) . By extrapolation the LD 50 value of pyrenocine A for sunflower pro toplasts is approximately 1 ppm. Thus the Helianthus protoplast viability technique is, as expected, a more sensitive bioassay for compound I than those utilising whole leaf tissue of sunflower [14, 16] . Similarly, pyrenocine A was previously demonstrated to ex press high levels of activity against isolated proto- 
Concentration of pyrenocine A (ppm)
* Viability was scored after treatm ent for 4 days and is expressed relative to the viability of untreated control protoplasts (64% viability after 4 days).
plasts of onion (Allium cepa L., Liliaceae) (LD 50 = 0.4 ppm) [14] . Our current observations are thus not only consistent with the earlier report on the potent activity of pyrenocine A against protoplasts but also serve to amplify and reiterate the earlier findings [1, 14] on the lack of specificity of this metabolite with respect to taxonomy of the target organism. Pyrenocine B was not assayed for phytotoxicity in these studies. The apparent weak activity of pyre nocine B previously reported against seedling elon gation [1] may be explained by its spontaneous con version in aqueous media to the toxic pyrenocine A. as postulated by Sparace et al. [14] . The same au thors reported pyrenocine B to lack toxicity to onion protoplasts [14] .
Mycelial growth from cultures grown on the com plex SEM medium was considerably less than that obtained from modified Czapek-Dox broth, the car bohydrate concentration of which was 20 times high er than that of SEM (Table II) . After culture for 21 days on SEM, concentrations of pyrenocine A and pyrenocine B were ca. 4 and 3.2 mg per liter of culture filtrate respectively. In contrast, following culture for the same time period on CD medium, neither pyrenocine A nor pyrenocine B were de tected. After incubation in SEM for a further 7 days the concentrations of total pyrenocines had declined, to give values of 1.7 and 1.6 mg per liter for com pounds I and II respectively. In neutral aqueous so lution the conversion of pyrenocine A to pyrenocine B is known to occur via a Michael addition of H20 across the 8,9 double bond of 1, resulting in an equilibrium mixture of the two compounds, of which pyrenocine A predominates [14, 17] . We observed that when our isolate was grown in CD medium for a period of 4 weeks, only pyrenocine B was detected (Table II) . In this medium the pH of the culture was found to decrease to ca. 4.5. Under these conditions the above Michael addition to form II is favoured. Subsequently, by adjustment of the culture filtrate to pH 7.0 prior to extraction (see Experimental), the addition reaction is effectively quenched. This could account for the fact that pyrenocine A (I) was not observed to co-occur with its water adduct (II) fol lowing fermentation in CD medium. An alternative explanation is that pyrenocine B is a .bona fide fungal metabolite, as opposed to being derived solely from I by non-enzymic means, the biosynthesis of which is proportionately enhanced by this particular medium. Notwithstanding, the much greater production of both compounds in the medium containing sunflower leaf extract (SEM) as compared with the presence of only trace amounts of pyrenocines following growth on CD medium is a striking result. The effect of components from higher plants on the metabolism of microorganisms with which they interact in nature has, however, been reported previously (e.g. [18] [19] [20] [21] ).
The production of the same uncommon metabolite (pyrenocine A) by three different fungal species be longing to unrelated genera, namely Pyrenochaeta (Sphaeropsidales), Penicillium (Eurotiales) and the present Alternaria species (Dematiaceae) is some what unexpected, although analogous phenomena have been described. For example, the production of the cephalosporin antibiotics by species of Streptomyces, Aspergillus and Cephalosporium is known [22] . This situation is postulated not to result from parallel evolution, but rather to be due to 'promiscu ous' transfer of genetic material between organisms which would be incompatible in more established gene transfer mechanisms. Methods of indiscrimi nate gene transfer postulated by Luckner [22] in clude (protopolast) fusion, and various genetic vec tors such as plasmids and phages. The transfer of the genes required for pyrenocine A biosynthesis be tween Alternaria, Pyrenochaeta and Penicillium, or certain of their ancestral forms, is an intriguing possi bility.
Experimental

Isolation and characterization of the fungus
Pieces of H. tuberosus leaf tissue at the perimeter of necrotic lesions and beyond were excised and washed thoroughly with sterile water prior to plating on V-8 juice agar. The plates were incubated at 28 °C to reveal dark-pigmented filamentous growth after 48 h. Sub-cultures from this growth on the same medium were free of bacterial contaminants and axenic. Incubation to induce sporulation was per formed under continuous illumination. Conidial morphology was examined microscopically using wet mounts at magnifications of 150X and 600X.
Fermentation and isolation o f the metabolites
Sunflower extract medium (SEM) contained the hot aqueous extract of 100 g fresh weight of sun flower leaves and 5 g of sucrose per L of medium. Modified Czapek Dox broth had the composition as given in [12] . Batches of 100 ml of medium in 500 ml Erlenmeyer flasks were inoculated with an agar plug from a culture growing on V-8 juice agar. Liquid cultures were incubated at 28 °C on a gyratory shaker (170 rpm.) for 21 or 29 days. The mycelial mat was removed and weighed after drying, but was not extracted. The culture filtrate was adjusted to pH 7.0 prior to extraction (X2) with equal volumes of diethyl ether. The organic phases were combined, dried over anhydrous Na2S 0 4 and reduced to a small volume for TLC (Merck, silica gel, 0.25 mm, Et20). Rf 1 = 0.31, R f 11 = 0.11. Compounds were eluted with CHC13. HPLC was performed using a Waters Data-and Z-Module system equipped with a reverse phase C18 jaBondapak column (5 ja); MeCN -H20 , 6:4 at a flow rate of 1.0 ml/min, UV detector (Wa ters model 481) at 260 nm. Mass spectra were re corded on a VG 7070 E, and NMR spectroscopy was performed on a Varian XL 300 instrument.
Bioassays
(i) Leaves
Plants were grown in a greenhouse under standard conditions at 26 °C day/18 °C night with a 16 h photoperiod. Leaves were excised and placed on moist filter paper in Petri dishes. Pyrenocine A, pre pared at various concentrations in 2% aqueous DMSO, was applied to the adaxial leaf surface as 10 j^l droplets, either over needle punctures or to the intact cuticle. Control leaves were treated with 2% aqueous DMSO in the presence and absence of a needle puncture. Petri dishes were sealed to prevent desiccation of the leaf tissue and the applied drop lets. Treated leaves were incubated at 24 ± 2 °C with ca. 12 h photoperiod, and examined daily for development of symptoms.
(ii) Protoplasts Sunflower protoplasts for bioassay were prepared from cotyledons of aseptically grown plants. The ex cised tissue was preplasmolyzed for 6 h in a hyper tonic solution, the main ingredient of which was sucrose at a concentration of 102.6 g/1, together with mineral salts, vitamins and hormones. Plasmolyzed tissue was digested with a mixture of cellulase and meicellase (Meiji Seika Kaisha Ltd., Tokyo, Japan) for 16 h at ca. 25 °C. Isolated protoplasts were sus pended in a modified Murashige-Skoog medium at a concentration of 105 ml. Solutions of pyrenocine A in aqueous DMSO were added to protoplast suspen sions to give a final DMSO concentration of 0.15%. Control protoplast suspensions were incubated in 0.15% aqueous DMSO. After incubation at 22 °C for 4 days protoplast viability was determined by the fluorescein diacetate staining technique as described in [15] . Viability for each pyrenocine A treatment was expressed as a percentage of the control value.
